CIDEA 抗体
(Cell Death-Inducing DFFA-Like Effector A (CIDEA))
This gene encodes the homolog of the mouse protein Cidea that has been shown to activate apoptosis. This activation of apoptosis is inhibited by the DNA fragmentation factor DFF45 but not by caspase inhibitors. Mice that lack functional Cidea have higher metabolic rates, higher lipolysis in brown adipose tissue and higher core body temperatures when subjected to cold. These mice are also resistant to diet-induced obesity and diabetes. This suggests that in mice this gene product plays a role in thermogenesis and lipolysis. Alternatively spliced transcripts have been identified. [provided by RefSeq, Aug 2010].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CIDEA 抗体 (AA 1-253) | 人 | 小鼠 Monoclonal |
|
|
|
| CIDEA 抗体 (AA 1-51) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 1-253) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 181-209) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 1-253) | 人 | 小鼠 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (Cy7) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (AbBy Fluor® 680) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (Cy5) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (AbBy Fluor® 750) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (AbBy Fluor® 555) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (AbBy Fluor® 594) | 人 | 兔 Polyclonal |
|
|
|
| CIDEA 抗体 (AA 85-180) (AbBy Fluor® 647) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
4 references - 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 4B9
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 1-253
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-51
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-253
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB34139
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 181-209, C-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 181-209
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-253
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy7
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 594
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 647
- 抗体亚型
- IgG
- 抗原表位
- AA 85-180
Latest Publications for our CIDEA 抗体
: "Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway." in: Biochimica et biophysica acta. Molecular and cell biology of lipids, Vol. 1864, Issue 8, pp. 1091-1102, (2019) (PubMed).
: "The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis." in: Scientific reports, Vol. 9, Issue 1, pp. 7501, (2019) (PubMed).
: "An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice. ..." in: Nature medicine, Vol. 22, Issue 10, pp. 1120-1130, (2016) (PubMed).
: "Rose hip supplementation increases energy expenditure and induces browning of white adipose tissue." in: Nutrition & metabolism, Vol. 13, pp. 91, (2016) (PubMed).
: "Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors." in: Journal of the National Cancer Institute, Vol. 104, Issue 3, pp. 189-210, (2012) (PubMed).
: "Differential regulation of CIDEA and CIDEC expression by insulin via Akt1/2- and JNK2-dependent pathways in human adipocytes." in: Journal of lipid research, Vol. 52, Issue 8, pp. 1450-60, (2011) (PubMed).
: "Differential roles of CIDEA and CIDEC in insulin-induced anti-apoptosis and lipid droplet formation in human adipocytes." in: Journal of lipid research, Vol. 51, Issue 7, pp. 1676-84, (2010) (PubMed).
: "Cidea is associated with lipid droplets and insulin sensitivity in humans." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 22, pp. 7833-8, (2008) (PubMed).
: "The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis." in: Scientific reports, Vol. 9, Issue 1, pp. 7501, (2019) (PubMed).
: "An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice. ..." in: Nature medicine, Vol. 22, Issue 10, pp. 1120-1130, (2016) (PubMed).
: "Rose hip supplementation increases energy expenditure and induces browning of white adipose tissue." in: Nutrition & metabolism, Vol. 13, pp. 91, (2016) (PubMed).
: "Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors." in: Journal of the National Cancer Institute, Vol. 104, Issue 3, pp. 189-210, (2012) (PubMed).
: "Differential regulation of CIDEA and CIDEC expression by insulin via Akt1/2- and JNK2-dependent pathways in human adipocytes." in: Journal of lipid research, Vol. 52, Issue 8, pp. 1450-60, (2011) (PubMed).
: "Differential roles of CIDEA and CIDEC in insulin-induced anti-apoptosis and lipid droplet formation in human adipocytes." in: Journal of lipid research, Vol. 51, Issue 7, pp. 1676-84, (2010) (PubMed).
: "Cidea is associated with lipid droplets and insulin sensitivity in humans." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 22, pp. 7833-8, (2008) (PubMed).
Aliases for CIDEA 抗体
cell death-inducing DFFA-like effector a (CIDEA) 抗体cell death-inducing DNA fragmentation factor, alpha subunit-like effector A (Cidea) 抗体
cell death-inducing DFFA-like effector a (Cidea) 抗体
cell death-inducing DFFA-like effector a (cidea) 抗体
cell death-inducing DFFA-like effector a L homeolog (cidea.L) 抗体
AW212747 抗体
CIDE-A 抗体
cide-a 抗体
CIDEA 抗体
MGC89985 抗体
您还需要查找其他产品吗？
You are here:
